Validation and Reliability of the Parents Assessment of Protective Factors Survey

September 23, 2021 updated by: Perran Boran, Marmara University

Strengthening Families to Prevent Child Neglect and Abuse With Community Based Protective Approaches: Culturally Appropriate Program Development and Educational Design

Neglect and abuse, which have a devastating effect on children, can be prevented with community-based education programs aimed at strengthening families. The study aimed to validate and determine reliability of the "Parents Assessment of Protective Factors (PAPF) survey" and to develop a culturally appropriate program and educational design for strengthening families.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The American Center for Social Policy Studies (CSSP) Center for Quality Improvement in Early Childhood (QIC_EC) defined protective factors that will form the basis of programs designed to prevent neglect and abuse, with community-based approaches. Community-based programs for primary prevention should be developed to prevent neglect and abuse, before it occurs. Existing studies in our country show that there is rarely a focus on preventing adverse childhood experiences with primary preventive approaches. Most of the studies are school-based, and aimed at increasing awareness of children and families about abuse.

This study aimed to evaluate the Turkish translation of the PAPF survey for validity and reliability and to adapt a culturally appropriate program and educational design for strengthening families, with a multidisciplinary team.

In the first step of the study, Turkish validity and reliability of the Parents Assessment of Protective Factors (PAPF) survey, will be conducted and applied to parents to determinate the protective factors. Turkish version of Adverse Childhood Experience Questionnaire (ACE), will be applied simultaneously with the PAPF survey, to identify adverse childhood experiences of parents that might affect parental resilience, parenting characteristics, and family dynamics.

In the second phase of the study, community-based family education programs that are currently being implemented in different countries will be reviewed by a multidisciplinary team (healthcare professionals, social workers and non-governmental organizations). A culturally appropriate educational primary prevention program for child neglect and abuse will be developed.

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Marmara University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Parents of children aged between 0 to 8 years

Description

Inclusion Criteria:

  • Parents of children aged between 0 to 8 years
  • Ability to read and complete the self-assessment questionnaires

Exclusion Criteria:

  • Parents who do not give consent to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Turkish Validation of The Parents Assessment of Protective Factors (PAPF) Survey
Time Frame: Baseline
Parents Assessment of Protective Factors (PAPF) Survey will be validated
Baseline
Turkish Reliability of The Parents Assessment of Protective Factors (PAPF) Survey
Time Frame: Baseline
Parents Assessment of Protective Factors (PAPF) Survey will be tested for reliability
Baseline
Turkish Reliability of The Parents Assessment of Protective Factors (PAPF) Survey
Time Frame: at 6 months
Parents Assessment of Protective Factors (PAPF) Survey will be tested for reliability
at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subscale scores for each protective factors
Time Frame: Baseline
Parents Assessment of Protective Factors (PAPF) Survey subscale scores will be computed. Higher scores indicate greater protective factors.
Baseline
Protective Factors Index (PFI)
Time Frame: Baseline
Parents Assessment of Protective Factors (PAPF) Survey total scores will be summed
Baseline
Adverse Childhood Events
Time Frame: Baseline

Adverse Childhood Events will be measured with Adverse Childhood Events Questionnaire.

Higher scores indicate increased exposure to trauma, which have been associated with a greater risk of negative consequences.

Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2021

Primary Completion (Anticipated)

October 1, 2022

Study Completion (Anticipated)

October 1, 2023

Study Registration Dates

First Submitted

September 23, 2021

First Submitted That Met QC Criteria

September 23, 2021

First Posted (Actual)

October 4, 2021

Study Record Updates

Last Update Posted (Actual)

October 4, 2021

Last Update Submitted That Met QC Criteria

September 23, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 09.2021.848

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Requests for wider sharing of data (for example in response to publications about the study and willingness to share), will be addressed on a case-by-case basis. Any data sharing request will be made to investigators through a pre-defined data requisition form. This form will contain information about the applicant, institution, purpose of data request, study objectives, ethical clearance of the study, etc. Once a request has been made the data governance body will discuss if that request was appropriate; data will be released following signing of the data sharing agreement. The data will be stored on the Marmara University servers and not be deposited in any 'community' database.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Family

Subscribe